Systemic inflammation and mortality in chronic obstructive pulmonary disease.
about
The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancerInhalation of environmental stressors & chronic inflammation: autoimmunity and neurodegenerationLower extremity and carotid artery disease in COPDEmphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD.Repression of CC16 by cigarette smoke (CS) exposure.Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cellsIncreased leptin/leptin receptor pathway affects systemic and airway inflammation in COPD former smokers.Relationships and Inflammation across the Lifespan: Social Developmental Pathways to Disease.Adipokine CTRP-5 as a Potential Novel Inflammatory Biomarker in Chronic Obstructive Pulmonary DiseaseChronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk.Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007-2010.Prospective study of inhaled corticosteroid use, cardiovascular mortality, and all-cause mortality in asthmatic women.Chronic obstructive pulmonary disease: a view from the NHLBI.The importance of C-reactive protein and other inflammatory markers in patients with chronic obstructive pulmonary disease.Year-in-review 2010: asthma, COPD, cystic fibrosis and airway biology.Chronic obstructive pulmonary disease and lung cancer: new molecular insights.Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice.Systemic inflammation and comorbidities in chronic obstructive pulmonary disease.Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.An omics strategy for discovering pulmonary biomarkers potentially relevant to the evaluation of tobacco products.Indices of iron homeostasis correlate with airway obstruction in an NHANES III cohortClinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis.Subclinical carotid atherosclerosis in patients with chronic obstructive pulmonary disease: a meta-analysis of literature studies.CCR4+ Regulatory T Cells Accumulate in the Very Elderly and Correlate With Superior 8-Year Survival.The endocrinologic changes in critically ill chronic obstructive pulmonary disease patients.Effects of hypoxia on adipose tissue expression of NFκB, IκBα, IKKγ and IKAP in patients with chronic obstructive pulmonary disease.Airflow limitation in smokers is associated with subclinical atherosclerosis.Study of inflammatory markers and BODE index in chronic obstructive pulmonary disease.Delayed resolution of inflammatory response compared with clinical recovery in patients with acute exacerbations of chronic obstructive pulmonary disease.Fatigue Affects Health Status and Predicts Mortality Among Subjects with COPD: Report from the Population-Based OLIN COPD Study.Fetuin-A is associated with disease severity and exacerbation frequency in patients with COPD.Association between arterial stiffness and pulmonary function in hypertensive patients.Associations of pulmonary function with serum biomarkers and dialysis adequacy in patients undergoing peritoneal dialysis.Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population.Apoetm1Unc mice have impaired alveologenesis, low lung function, and rapid loss of lung function.
P2860
Q24625481-1703D800-FC44-432D-9E18-AAF73882E6D5Q28388503-1EECFE7A-DDC0-459E-8E8F-8A0DA194C1E9Q28587857-805EE9D1-AC16-4BDA-874F-5C313D86FBCAQ34053824-0996FC12-7575-4463-8B39-A32562F93AC1Q35032256-9CC155C6-AADC-4BF9-9A80-B6BC0284F17BQ35156050-F8D29444-3DDA-449B-9FFF-46323E512294Q35557412-A3CCEC71-4CF4-44C0-9741-92629AF45D99Q35572794-0B58A63D-5CF0-46C2-B21F-FAE7D9C15A66Q36194869-645DB064-3111-42C9-9476-7796E6E6EF1FQ36446491-F215BFC0-53D0-4877-BAC2-15125D327561Q36539136-383C608E-F629-4E72-8E26-74C5FE72F750Q37098772-C2B280F4-8E94-488B-849F-C27999E6BE6AQ37287153-C8CDE3F9-5A7E-4650-9171-46EB1E38D57AQ37389399-B1A93522-396B-4927-9D2C-B3F799753671Q37845433-9F6331F7-E089-4F68-8EA0-E567CF2C4B85Q37856648-8685D71A-CFF7-407D-8C61-EF4999EB4D17Q37964807-0D44ABF2-541D-4B26-A6C0-180E27293B7DQ38006928-63AFAB65-7AA8-4F1E-8239-7B8026FC01A2Q38056532-11DE051A-E2A5-483C-B91B-14ED625297B8Q38066244-9DAEEF67-57D0-4734-8464-E085F6D2A898Q38633137-013EB13E-88FA-4124-8716-0F44C55788F6Q38737113-4612E7C9-1FDC-42F9-9A8E-60271507512DQ38888060-E537FF91-0922-4740-9CEE-21994BB39B2AQ41102838-D4B28D58-5816-4524-8E8E-23FB8832C7D2Q42951424-3B5F0166-30F3-4085-A09C-95915DFF7500Q45231659-93C05195-0D79-4815-A20B-B3E8D23FE193Q46309534-E06D97EE-7A5C-4B46-976C-223E0B3262DCQ47214661-1A8B25ED-E156-4036-879C-02288A3C1652Q48235233-4C1AA394-0E4A-4853-AB66-95B2016FB778Q50635241-BE836291-D190-4EAF-A767-BBB5E34F145DQ50883932-D7F37B0E-122D-44AC-B380-0CF057C5F97DQ51490512-E8D52D33-3E16-45D4-9DDA-8D810E92FCCFQ51547824-7F164E81-2AAB-4B82-B83F-F708386203FEQ51614615-6FAC1CC2-F008-4518-83C6-67F82D3912A0Q51961868-3F077712-2B6A-44FA-8F3E-95D1279139C5
P2860
Systemic inflammation and mortality in chronic obstructive pulmonary disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Systemic inflammation and mortality in chronic obstructive pulmonary disease.
@ast
Systemic inflammation and mortality in chronic obstructive pulmonary disease.
@en
type
label
Systemic inflammation and mortality in chronic obstructive pulmonary disease.
@ast
Systemic inflammation and mortality in chronic obstructive pulmonary disease.
@en
prefLabel
Systemic inflammation and mortality in chronic obstructive pulmonary disease.
@ast
Systemic inflammation and mortality in chronic obstructive pulmonary disease.
@en
P356
P1476
Systemic inflammation and mortality in chronic obstructive pulmonary disease.
@en
P2093
S F Paul Man
P304
P356
10.1139/Y06-093
P577
2007-01-01T00:00:00Z